[Retracted] Composite Dietary Antioxidant Index and Plasma Levels of Soluble Klotho: Insights from NHANES

He, Huiqin; Chen, Xin; Miao, Da; Zhang, Hongxia; Wang, Yu; He, Xingkang; Chen, Xiaoli; Dai, Ning

doi:https://doi.org/10.1155/2023/3524611

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Results Discussion Abbreviations Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article Retraction

!

This article has been Retracted. To view the article details, please click the ‘Retraction’ tab above.

Special Issue

Nutraceuticals as Anti-aging Medicine

View this Special Issue

Research Article | Open Access

Volume 2023 | Article ID 3524611 | https://doi.org/10.1155/2023/3524611

[Retracted] Composite Dietary Antioxidant Index and Plasma Levels of Soluble Klotho: Insights from NHANES

Huiqin He,¹Xin Chen,¹Da Miao,²Hongxia Zhang,¹Yu Wang,¹Xingkang He,¹Xiaoli Chen,¹and Ning Dai¹

Academic Editor: Aamir Jalil

Received22 Jul 2022

Revised10 Oct 2022

Accepted24 Nov 2022

Published07 Feb 2023

Abstract

Objectives. The association between dietary antioxidants and soluble Klotho (S-Klotho) levels remains unknown. We investigated to explore whether the composite dietary antioxidant index (CDAI) was associated with serum levels of S-Klotho in the middle-aged population. Methods. Eligible participants were identified from the National Health and Nutrition Examination Surveys (NHANES) from 2007 until 2016. The CDAI was calculated from the intake of six dietary antioxidants. The serum levels of S-Klotho were measured via enzyme-linked immunosorbent assay (ELISA). Generalized linear and nonlinear models were established to analyze the relationship between CDAI and S-Klotho levels. Results. Based on the S-Klotho quartiles, S-Klotho levels were higher in young women, Blacks, higher education, never smokers, lower waistlines, no medication use, and those with higher CDAI. Univariate analysis revealed that age, gender, race, smoking status, body mass index, waistline, and medication use were associated with serum levels of S-Klotho. When potential confounders were controlled, CDAI was significantly associated with S-Klotho levels. Subgroup analysis also revealed that this association remained significant in individuals who had the highest quartiles of CDAI, aged population (>60 years), male, and never smoker. A nonlinear relationship was observed between the CDAI and S-Klotho plasma concentrations. Conclusion. CDAI was positively correlated with plasma levels of S-Klotho after controlling for covariates. Further studies are needed to validate the current findings and explore the fundamental mechanisms.

1. Introduction

Oxidative stress is caused by the imbalance between oxidant generation and elimination, which contributes to multiple chronic diseases, such as cancer, aging, neurodegenerative, and cardiovascular diseases [1–3]. Overwhelming release of reactive oxygen and nitrogen species (RONS) [4] by endogenous and exogenous mechanisms can lead to deleterious effects, impaired immune defense, and signaling events [5, 6]. It is believed that accumulation of oxidative damage caused by RONS leads to impaired macromolecule synthesis (lipids, DNA, and proteins) and aging [7, 8]. For example, oxidative stress damages telomere attrition and impairs their capacity for repair, which accelerates aging and increases the risk of age-related diseases due to oxidative stress [9–11]. Conceptually, antioxidants have been postulated to protect biological systems from free radical toxicity, acting as scavengers of oxidants [12, 13]. Whether antioxidants improve adverse health consequences remains a hotly debated topic [14].

As an age-suppressor gene, Klotho is considered to originally extend life expectancy [15]. Mutations in Klotho resulted in shortened life spans in addition to multiple disorders resembling premature aging in humans [16–18]. In contrast, overexpression of Klotho in mice slowed down the aging process and increased life expectancy by 20% to 30% [17]. In humans, serum levels of Klotho were also decreased with age [19, 20]. Espuch-Oliver et al. demonstrated that soluble levels of Klotho were decreased in healthy-aged individuals duo to aging-related physiological declines [21]. They proposed that the soluble Klotho (S-Klotho) level through ELISA measurement could be considered a simple and meaningful marker of aging that can improve quality of life for the elderly [21]. Actually, the Klotho gene encoded several forms of Klotho protein, including membrane bound form and secreted form Klotho [22]. The membrane bound Klotho was primarily expressed in the renal distal convolution distal convoluted tubules of the kidney as well as in the brain [17]. The extracellular region of membrane bound Klotho could be released into the blood and urine by cleavage of α- and β-secretases [23]. The cleaved Klotho had pleiotropic properties and functioned as a humoral factor, known as the soluble Klotho (S-Klotho) [23]. Further, Klotho deficiency was related to multiple aging-related conditions, such as kidney disease, hypertension, and cancer [24]. Nakanishi et al. suggested that low-serum Klotho concentrations were associated with multiple preclinical disorders, such as overweight, abdominal obesity, hypertension, and hyperlipidemia [25]. Qiao et al. observed an inverse association between serum levels of S-Klotho and risk of pan-cancer [26]. Besides, serum levels of S-Klotho were also related to inflammatory cytokines and showed several protective effects. Martín-Núñez et al. found that reduced levels of S-Klotho were associated with the proinflammatory status, such as higher ratio of tumor necrosis factor-alpha/interleukin-10 and the C-reactive protein level [27]. Wu et al. also demonstrated that the serum levels of S-Klotho were significantly and inversely associated with four well-recognized inflammation-related biomarkers (white blood cell count, mean platelet volume, C-reactive protein, and uric acid) in the cohort [28]. Several experimental models demonstrated that upregulation of endogenous Klotho or exogenous administration of Klotho both could suppress renal fibrosis and maintain kidney function in chronic kidney disease [29]. Considering the protective effects of S-Klotho, we were curious about the association between S-Klotho levels and oxidative stress. Previously, Klotho was reported to downregulate oxidative stress [30]. However, whether antioxidants could influence S-Klotho levels has yet to be studied.

Composite dietary antioxidant index (CDAI) is a measure of individual antioxidant profile based on a combination of dietary antioxidants, including manganese, selenium, zinc, and vitamins A, C, and E [31]. The CDAI was developed to evaluate and reflect the overall impact of dietary antioxidants on health. Previous studies found that high CDAI was related to a decreased risk of various types of cancer [32–34]. To our knowledge, the relationship between CDAI and plasma levels of Klotho has not been evaluated. Whether or not dietary antioxidants influence S-Klotho levels remains largely unknown. In the current study, based on National Health and Nutrition Examination Survey (NHANES), we explored and evaluated the relationship between CDAI and S-Klotho in the middle-aged population.

2. Method

2.1. Study Population

The NHANES, which is a series of cross-sectional surveys, represents noninstitutionalized US civilian population (https://www.cdc.gov/nchs/nhanes/index.htm). The NHANES dataset includes demographic, socioeconomic, dietary, and health-related questionnaire data, which was collected through in-person interviews, physical and physiological examinations, and extensive and laboratory testing. NHANES was approved by the National Center for Health Statistical research ethics review committees and publicly available (https://wwwn.cdc.gov/nchs/nhanes/). We combined five NHANES cycles (NHANES 2007-2008, 2009-2010, 2011-2012, 2013-2014, and 2015-2016 cycle). The inclusion criteria were as follows: those who had complete data about age, gender, race, marital status, education, poverty, smoke status, energy intake, body measurement, waist circumference, use of medication, diabetes mellitus and dietary antioxidant intake, and S-Klotho level. Participants with missing or unknown data were excluded. During 2007-2008, 2009-2010, 2011-2012, and 2013-2014 study cycles, 13,760 individuals were selected to participate in the study. Individuals with missing information of composite dietary antioxidant index and serum S-Klotho level were excluded (). Besides, individuals with missing information of age, gender, race, marital status, education, poverty, smoke status, energy intake, body mass index (BMI), waist circumference, and medication use were also excluded (). Finally, 10,393 individuals with complete information were included in our analyses. All NHANES protocols were approved by the National Center for Health Statistics Research Ethics Review Board, and participants provided written informed consent. Since it used deidentified data without personally identifiable information, this study was exempted from Institutional Review Board review.

2.2. Calculation of CDAI

The calculation of CDAI was described previously and validated in another prospective cohort study [31]. In brief, six antioxidants (manganese, selenium, zinc, and vitamins A, C, and E) were standardized. The CDAI was based on the sum of these standardized consumptions. Each participant’s food and nutrient intake in the NHANES dataset was recorded based on nonconsecutive two-day 24-hour dietary recalls, based on interviews. On the first day, the participants were interviewed at the NHANES Mobile Examination Center and then 3 to 10 days later via telephone. The Food and Nutrient Database for Dietary Studies of the United States Department of Agriculture was used to calculate the intake of antioxidants, micronutrients, and total energy [35]. Based on the questionnaire interview, we determined the intake of dietary supplements during the past month, including dosage, frequency, and duration of consumption [36].

2.3. Measurement of S-Klotho Levels

According to the description available on the NHANES website [19], the levels of S-Klotho of each participate were quantified using commercially available ELISA (IBL International, Japan) of frozen serum specimens. These frozen serum specimens were stored at −80°C at the Centers for Disease Control and Prevention. IBL ELISA for measurement of Klotho concentration in human samples had been extensively validated prior to the start of the study. Available serum samples of Klotho concentration were obtained from 40- to 79-year-old participants in NHANES. In summary, standard curves and relative signals of calibrator concentrations consistently met the manufacturer’s criteria. The linearity of the assay was evaluated using two samples with very high and high Klotho concentrations. The intra-assay precision was obtained from two Klotho samples, and the reference ranges of Klotho concentration were evaluated in 114 healthy donors. In accordance with the manufacturer’s protocol, all samples were analyzed in duplicate, and the final value was calculated based on the average of the two values. All results of analyses automatically transmitted to the laboratory Oracle Management System and evaluated by the area supervisor. Samples with greater than 10% duplicate findings were highlighted for repeated analysis. All the results were examined to ensure that they met the laboratory’s routine acceptance standards before release.

2.4. Assessment of Covariates

To assess the influence of potential confounding factors, we selected several important covariates, including individual age (years), gender (male/female), race (White, non-Hispanic White/Black, non-Hispanic Black/Mexican, Mexican American/other, other Hispanic, other Race—including multiracial), marital status (no married/married), education level (grade or less/high school/some college/college or more), poverty (income-to-poverty ratio), smoking status (never/former/now smoker), total energy intake (Kcal/day), BMI, waist circumference, and use of medication.

2.5. Statistical Analysis

We gathered data from NHANES project via nhanesR. In order to illustrate the complexity of survey design, we incorporated clustering and stratification across analyses to reduce the probability of unequal selection and oversampling. For the categorical variables, the weighted chi-square test was used, and for the continuous variables, weighted linear regression model was adopted. To evaluate the relationship between CDAI and the level of S-Klotho, two models of linear regression were adopted. Model 1 was adjusted for age, gender, and race. Model 2 was adjusted for age, gender, and race, marital status, poverty, education, energy intake, BMI, waist circumference, smoke status, and medication use. The potential nonlinear association was investigated using a generalized additive model. A two-stage linear regression model was also used to determine the inflection point. All statistical analyses were performed using R packages and EmpowerStats. A value < 0.05 was considered as statistically significant.

3. Results

The current study included 10,393 participants in the final analysis based on inclusion and exclusion criteria. The baseline features of included population were summarized in Table 1. Within the S-Klotho quartiles, significant differences were observed regarding age, gender, race, education status, smoking status, waist circumference, medication use, and CDAI. The individuals with higher levels of S-Klotho were younger, Black, had higher education, had never smoked, had a smaller waistline, no medication use, and had higher CDAI scores. There was no difference regarding marital status, poverty, BMI, and energy intake.

Further univariate analysis of associations between S-Klotho levels and various characteristics revealed that age, gender, smoke status, BMI, and waistline were inversely associated with levels of S-Klotho (Table 2). The Black and no medication use were positively associated with levels of S-Klotho (Table 2). There was a positive relationship between CDAI and serum levels of S-Klotho, although the relationship was not statistically significant (Table 2). After adjusting for age, gender, and race confounders, CDAI was significantly associated with S-Klotho levels (Table 3). In subgroup analysis, the positive association was more apparent in individuals with the highest quartiles of CDAI, all age groups, all gender groups, and never-smokers. Higher antioxidant intakes of vitamins A and C were significantly associated with higher levels of S-Klotho (Table 3). After controlling for additional confounders, such as marital status, poverty, education, energy intake, BMI, waist circumference, smoke status, and use of medication, CDAI was still significantly associated with S-Klotho levels (Table 3). In subgroup analysis, this positive association remained significant in individuals who had the highest quartiles of CDAI, older than 60 years, male gender, and who never smoked. Higher intake of vitamin A was significantly associated with higher levels of S-Klotho. With this relationship in mind, we further performed a threshold effect analysis using a nonlinear model. As Figure 1 and Table 4 shown, the serum level of S-Klotho increased by 3.38 pg/ml when the CDAI increased by one unit ().

4. Discussion

In the current study, we demonstrated that overall antioxidant intakes, indicated by the CDAI, were positively and significantly associated with plasma levels of S-Klotho after adjusting for multiple covariates in the middle-aged population based on NHANES. In the aged, male, and never-smoking population, this positive association was more apparent. In the subgroup analysis of individual antioxidant components, a higher intake of vitamin A was significantly related to higher plasma levels of S-Klotho. Our results suggested that overall dietary antioxidants might influence serum levels of antiaging protein, S-Klotho.

The concentrations of RONS overwhelmingly contribute to oxidative stress, which leads to cell and tissue damage [37]. To maintain a steady state of biological redox, antioxidants may scavenge oxidants, which protects against oxidative stress. As a result, dietary antioxidants mitigate the damaging effects of oxidative stress and contribute to health [38]. CDAI represents comprehensive measurement of total antioxidant levels in the diet and is widely used in many studies. Proinflammatory cytokines, such as interleukin-1b and tumor necrosis factor-alpha, were inversely correlated with CDAI [39]. Several epidemiological studies showed that higher CDAI levels were significantly associated with reduced risk of various types of cancer. Wright et al. first showed that the combination of dietary antioxidants reduced the risk of lung cancer among male smokers [31]. Paragomi et al. showed that the overall levels of dietary antioxidants decreased the risk of pancreatic cancer [34]. Yu et al. reported an inverse relationship between CDAI and the risk of colorectal cancer, suggesting that antioxidants might reduce the incidence of colorectal cancer in the population [32]. Besides, dietary antioxidants were also reported to be associated with mortality, although not consistently. Wang et al. observed that higher intakes of antioxidants were associated with reduced mortality risk from all causes and cardiovascular disease in diabetic adults [40]. According to other studies, higher intakes of magnesium, zinc, selenium, and vitamins A, C, and E were inversely related to reduced mortality risk [41–43]. However, Genkinger et al. reported that no significant relationships existed between dietary intakes of vitamins C, E, and overall mortality [44].

However, evidence is limited to suggest any relationship between dietary antioxidants and levels of S-Klotho. Klotho was originally identified by Kuro-o et al. in 1997 as a potential an antiaging gene [15]. Mice deficient in Klotho had shortened life spans and multiple disorders resembling premature aging in humans, while mice with overexpression of Klotho could extend life span and slow down the aging process [16–18]. S-Klotho was cleaved by secretases from transmembrane Klotho and entered the circulatory system. In the circulation, S-Klotho served as the main functional form [16, 45]. Increasing evidence had suggested that Klotho could exert vasculo-protective effects and was critical for vascular health. Semba et al. showed that higher plasma levels of Klotho were independently associated with a reduced risk of cardiovascular disease in the community-based cohort [46]. Navarro-Gonzalez et al. found that lower serum Klotho concentrations were negatively associated with the presence and severity of coronary artery disease [47]. Recently, Pan et al. also showed that reduced baseline levels of circulating Klotho were associated with an increased risk of coronary artery disease in a prospective study [48]. Besides, a growing body of evidence also indicated that Klotho played a crucial anti-inflammation, antiaging, insulin resistance role, and prevention of age-related diseases. Serum levels of Klotho were reported to be associated with the proinflammatory status and well-recognized inflammatory biomarkers in the cohort [27]. The S-Klotho modulated the degree of insulin/insulin-like growth factor-1 signaling and Wnt pathway, in combating aging and tumor growth [49]. Kurosu et al. found that antiaging properties of Klotho were partly through the induction of insulin resistance. They observed that Klotho could inhibit insulin and IGF1 signaling to induce insulin resistance [16]. In addition, Klotho also suppressed cellular apoptosis and protected against hypoxia, oxidative stress, and cytotoxic drugs. Lim et al. reported that Klotho inhibited the phosphatidyl-inositol 3-kinase/serine-threonine kinase pathway, thereby enhancing manganese superoxide dismutase expression via FoxO3a in response to Tac-induced oxidative stress [30]. Consequently, Klotho interfered with insulin-like growth factor 1 signaling and increased resistance to oxidative stress. However, no study investigated whether dietary antioxidant intakes affected S-Klotho levels. The findings of the present study indicated that dietary antioxidants were positively associated with serum levels of S-Klotho after adjusting for covariates, especially for vitamin A. Previously, Azimzadeh et al. reported that vitamin D supplementation prevented the reduction in plasma Klotho in the elderly among a randomized, double-blinded, placebo-controlled clinical trial [50]. The underlying mechanism might be related to the presence of a vitamin D response element in the Klotho gene both in humans and mice [15, 51]. The expression of Klotho was upregulated by the binding of 1,25-dihydroxyvitamin D to the vitamin D receptor on the Klotho gene [15, 51]. However, whether vitamin A influenced the expression of Klotho required further investigations.

To the best of our knowledge, this is the first study to investigate the relationship between overall dietary antioxidants and plasma levels of S-Klotho in a population-based cohort, as well as its originality, a large sample size, representing of the noninstitutionalized U.S. population, and standardized methods of data collection are major strengths, which minimized any measurement bias. Our results indicated that CDAI was significantly associated with S-Klotho levels. Serum levels of S-Klotho increased more when CDAI score was greater than 1.5. Our findings provided some novel insights and clinical significances that increased dietary antioxidant intakes might positively modulate higher serum levels of S-Klotho, which could protect against age-related diseases. Nevertheless, the current study has some limitations. First, this study could not construct or confirm any causal inference due to its retrospective design. Second, despite adjusting for potential confounding, residual confounding may still exist, which might influence the relationship between CDAI and the level of S-Klotho. Third, it is unclear whether our findings based on the middle-aged population can be extended to younger population. Further studies are needed to determine if the benefit of dietary antioxidants can be extended to different populations.

In summary, our study demonstrated that CDAI was significantly associated with S-Klotho levels in middle-aged population after adjusting for multiple variables. The positive relationship was mainly observed in males, aged participants, and never smokers. Further studies are needed before the results can be generalized to other populations and establish the causal relationship between CDAI and S-Klotho levels based on investigation into the underlying mechanisms.

Abbreviations

CDAI:	Component dietary antioxidant index
S-Klotho:	Soluble Klotho
BMI:	Body mass index
NHANES:	National Health and Nutrition Examination Surveys
ELISA:	Enzyme-linked immunosorbent assay
RONS:	Reactive oxygen and nitrogen species.

Data Availability

The dataset was based on NHANES, which was publicly available and could be found below: https://www.cdc.gov/nchs/nhanes/.

Conflicts of Interest

All authors declare that there are no conflicts of interest.

Authors’ Contributions

Xingkang He, Xiaoli Chen, and Ning Dai designed the study. Xingkang He, Xin Chen, Huiqin He, Da Miao, Hongxia Zhang, Yu Wang, and Xiaoli Chen conducted data extraction, interpreted the study results, and wrote the first draft of the manuscript parts. Xingkang He revised the manuscript. Huiqin He and Xin Chen contributed equally to this work.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (no. 82203828). We acknowledged staffs and members of the National Center for Health Statistics of the Centers for Disease Control (CDC) and the participants who were involved in the National Health and Nutrition Examination Survey. Thanks to Zhang Jing (Shanghai Tongren Hospital) for his work on the NHANES database. His outstanding work, nhanesR package and webpage, makes it easier for us to explore NHANES database.

References

H. Haghi Aminjan, S. R. Abtahi, E. Hazrati, M. Chamanara, M. Jalili, and B. Paknejad, “Targeting of oxidative stress and inflammation through ROS/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation,” Life Sciences, vol. 232, p. 116607, 2019.
View at: Publisher Site | Google Scholar
O. Firuzi, R. Miri, M. Tavakkoli, and L. Saso, “Antioxidant therapy: current status and future prospects,” Current Medicinal Chemistry, vol. 18, no. 25, pp. 3871–3888, 2011.
View at: Publisher Site | Google Scholar
M. Sharifi-Rad, N. V. Anil Kumar, P. Zucca et al., “Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases,” Frontiers in Physiology, vol. 11, p. 694, 2020.
View at: Publisher Site | Google Scholar
Y. A. Hajam, R. Rani, S. Y. Ganie et al., “Oxidative stress in human pathology and aging: molecular mechanisms and perspectives,” Cell, vol. 11, no. 3, 2022.
View at: Google Scholar
M. Genestra, “Oxyl radicals, redox-sensitive signalling cascades and antioxidants,” Cellular Signalling, vol. 19, no. 9, pp. 1807–1819, 2007.
View at: Publisher Site | Google Scholar
S. I. Dikalov and R. R. Nazarewicz, “Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease,” Antioxidants & Redox Signaling, vol. 19, no. 10, pp. 1085–1094, 2013.
View at: Publisher Site | Google Scholar
I. Liguori, G. Russo, F. Curcio et al., “Oxidative stress, aging, and diseases,” Clinical Interventions in Aging, vol. 13, pp. 757–772, 2018.
View at: Publisher Site | Google Scholar
R. Buffenstein, Y. H. Edrey, T. Yang, and J. Mele, “The oxidative stress theory of aging: embattled or invincible? Insights from non-traditional model organisms,” Age, vol. 30, no. 2-3, pp. 99–109, 2008.
View at: Publisher Site | Google Scholar
G. Gavia-Garcia, J. Rosado-Perez, T. L. Arista-Ugalde, I. Aguiniga-Sanchez, E. Santiago-Osorio, and V. M. Mendoza-Nunez, “Telomere length and oxidative stress and its relation with metabolic syndrome components in the aging,” Biology, vol. 10, no. 4, p. 253, 2021.
View at: Publisher Site | Google Scholar
S. Reichert and A. Stier, “Does oxidative stress shorten telomeres in vivo? A review,” Biology Letters, vol. 13, no. 12, 2017.
View at: Google Scholar
W. Ahmed and J. Lingner, “Impact of oxidative stress on telomere biology,” Differentiation, vol. 99, pp. 21–27, 2018.
View at: Publisher Site | Google Scholar
A. M. Pisoschi and A. Pop, “The role of antioxidants in the chemistry of oxidative stress: a review,” European Journal of Medicinal Chemistry, vol. 97, pp. 55–74, 2015.
View at: Publisher Site | Google Scholar
J. M. Lu, P. H. Lin, Q. Yao, and C. Chen, “Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems,” Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 840–860, 2010.
View at: Publisher Site | Google Scholar
J. Luo, K. Mills, S. le Cessie, R. Noordam, and D. van Heemst, “Ageing, age-related diseases and oxidative stress: what to do next?” Ageing Research Reviews, vol. 57, p. 100982, 2020.
View at: Publisher Site | Google Scholar
Y. Xu and Z. Sun, “Molecular basis of Klotho: from gene to function in aging,” Endocrine Reviews, vol. 36, no. 2, pp. 174–193, 2015.
View at: Publisher Site | Google Scholar
H. Kurosu, M. Yamamoto, J. D. Clark et al., “Suppression of aging in mice by the hormone Klotho,” Science, vol. 309, no. 5742, pp. 1829–1833, 2005.
View at: Publisher Site | Google Scholar
M. Kuro-o, Y. Matsumura, H. Aizawa et al., “Mutation of the mouse Klotho gene leads to a syndrome resembling ageing,” Nature, vol. 390, no. 6655, pp. 45–51, 1997.
View at: Publisher Site | Google Scholar
H. Masuda, H. Chikuda, T. Suga, H. Kawaguchi, and M. Kuro-o, “Regulation of multiple ageing-like phenotypes by inducible Klotho gene expression in Klotho mutant mice,” Mechanisms of Ageing and Development, vol. 126, no. 12, pp. 1274–1283, 2005.
View at: Publisher Site | Google Scholar
Y. Yamazaki, A. Imura, I. Urakawa et al., “Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects,” Biochemical and Biophysical Research Communications, vol. 398, no. 3, pp. 513–518, 2010.
View at: Publisher Site | Google Scholar
T. Siahanidou, M. Garatzioti, C. Lazaropoulou et al., “Plasma soluble α-Klotho protein levels in premature and term neonates: correlations with growth and metabolic parameters,” European Journal of Endocrinology, vol. 167, no. 3, pp. 433–440, 2012.
View at: Publisher Site | Google Scholar
A. Espuch-Oliver, H. Vazquez-Lorente, L. Jurado-Fasoli et al., “References values of soluble alpha-Klotho serum levels using an enzyme-linked immunosorbent assay in healthy adults aged 18-85 years,” Journal of Clinical Medicine, vol. 11, no. 9, 2022.
View at: Google Scholar
Y. Matsumura, H. Aizawa, T. Shiraki-Iida, R. Nagai, M. Kuro-o, and Y. Nabeshima, “Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein,” Biochemical and Biophysical Research Communications, vol. 242, no. 3, pp. 626–630, 1998.
View at: Publisher Site | Google Scholar
O. M. Kuro, “The Klotho proteins in health and disease,” Nature Reviews. Nephrology, vol. 15, no. 1, pp. 27–44, 2019.
View at: Publisher Site | Google Scholar
J. H. Kim, K. H. Hwang, K. S. Park, I. D. Kong, and S. K. Cha, “Biological role of anti-aging protein Klotho,” Journal of Lifestyle Medicine, vol. 5, no. 1, pp. 1–6, 2015.
View at: Publisher Site | Google Scholar
K. Nakanishi, M. Nishida, M. Taneike, R. Yamamoto, T. Moriyama, and K. Yamauchi-Takihara, “Serum Klotho levels contribute to the prevention of disease progression,” International Journal of General Medicine, vol. 14, pp. 229–236, 2021.
View at: Publisher Site | Google Scholar
Y. Qiao, F. Liu, Y. Peng et al., “Association of serum Klotho levels with cancer and cancer mortality: evidence from National Health and Nutrition Examination Survey,” Cancer Medicine, vol. 12, 2023.
View at: Google Scholar
E. Martín-Núñez, J. Donate-Correa, C. Ferri et al., “Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study,” Aging, vol. 12, no. 2, pp. 1952–1964, 2020.
View at: Publisher Site | Google Scholar
S. E. Wu and W. L. Chen, “Soluble Klotho as an effective biomarker to characterize inflammatory states,” Annals of Medicine, vol. 54, no. 1, pp. 1520–1529, 2022.
View at: Publisher Site | Google Scholar
M. C. Hu, M. Kuro-o, and O. W. Moe, “Secreted Klotho and chronic kidney disease,” Advances in Experimental Medicine and Biology, vol. 728, pp. 126–157, 2012.
View at: Publisher Site | Google Scholar
S. W. Lim, L. Jin, K. Luo et al., “Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress,” Cell Death & Disease, vol. 8, no. 8, article e2972, 2017.
View at: Publisher Site | Google Scholar
M. E. Wright, S. T. Mayne, R. Z. Stolzenberg-Solomon et al., “Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers,” American Journal of Epidemiology, vol. 160, no. 1, pp. 68–76, 2004.
View at: Publisher Site | Google Scholar
Y. C. Yu, P. Paragomi, R. Wang et al., “Composite dietary antioxidant index and the risk of colorectal cancer: findings from the Singapore Chinese Health Study,” International Journal of Cancer, vol. 150, no. 10, pp. 1599–1608, 2022.
View at: Publisher Site | Google Scholar
A. Maugeri, M. Barchitta, R. Magnano San Lio, A. Scalisi, and A. Agodi, “Antioxidant and inflammatory potential of diet among women at risk of cervical cancer: findings from a cross-sectional study in Italy,” Public Health Nutrition, vol. 25, no. 6, pp. 1577–1585, 2022.
View at: Publisher Site | Google Scholar
P. Paragomi, R. Wang, A. Jin et al., “Abstract 3667: composite dietary antioxidant index and the risk of pancreatic cancer: findings from a prospective cohort study,” Cancer Research, vol. 82, 12_Supplement, pp. 3667–3667, 2022.
View at: Google Scholar
J. K. Ahuja, A. J. Moshfegh, J. M. Holden, and E. Harris, “USDA food and nutrient databases provide the infrastructure for food and nutrition research, policy, and practice,” The Journal of Nutrition, vol. 143, no. 2, pp. 241S–249S, 2013.
View at: Publisher Site | Google Scholar
E. D. Kantor, C. D. Rehm, M. Du, E. White, and E. L. Giovannucci, “Trends in dietary supplement use among US adults from 1999-2012,” JAMA, vol. 316, no. 14, pp. 1464–1474, 2016.
View at: Publisher Site | Google Scholar
H. Sies, “Oxidative stress: a concept in redox biology and medicine,” Redox Biology, vol. 4, pp. 180–183, 2015.
View at: Publisher Site | Google Scholar
B. Demmig-Adams and W. W. Adams 3rd, “Antioxidants in photosynthesis and human nutrition,” Science, vol. 298, no. 5601, pp. 2149–2153, 2002.
View at: Publisher Site | Google Scholar
H. N. Luu, W. Wen, H. Li et al., “Are dietary antioxidant intake indices correlated to oxidative stress and inflammatory marker levels?” Antioxidants & Redox Signaling, vol. 22, no. 11, pp. 951–959, 2015.
View at: Publisher Site | Google Scholar
W. Wang, X. Wang, S. Cao et al., “Dietary antioxidant indices in relation to all-cause and cause-specific mortality among adults with diabetes: a prospective cohort study,” Frontiers in Nutrition, vol. 9, p. 849727, 2022.
View at: Publisher Site | Google Scholar
A. Bagheri, S. Naghshi, O. Sadeghi, B. Larijani, and A. Esmaillzadeh, “Total, dietary, and supplemental magnesium intakes and risk of all-cause, cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis of prospective cohort studies,” Advances in Nutrition, vol. 12, no. 4, pp. 1196–1210, 2021.
View at: Publisher Site | Google Scholar
Z. Shi, A. Chu, S. Zhen et al., “Association between dietary zinc intake and mortality among Chinese adults: findings from 10-year follow-up in the Jiangsu Nutrition Study,” European Journal of Nutrition, vol. 57, no. 8, pp. 2839–2846, 2018.
View at: Publisher Site | Google Scholar
A. Jayedi, A. Rashidy-Pour, M. Parohan, M. S. Zargar, and S. Shab-Bidar, “Dietary antioxidants, circulating antioxidant concentrations, total antioxidant capacity, and risk of all-cause mortality: a systematic review and dose-response meta-analysis of prospective observational studies,” Advances in Nutrition, vol. 9, no. 6, pp. 701–716, 2018.
View at: Publisher Site | Google Scholar
J. M. Genkinger, E. A. Platz, S. C. Hoffman, G. W. Comstock, and K. J. Helzlsouer, “Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland,” American Journal of Epidemiology, vol. 160, no. 12, pp. 1223–1233, 2004.
View at: Publisher Site | Google Scholar
M. C. Hu, M. Shi, N. Gillings et al., “Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy,” Kidney International, vol. 91, no. 5, pp. 1104–1114, 2017.
View at: Publisher Site | Google Scholar
R. D. Semba, A. R. Cappola, K. Sun et al., “Plasma Klotho and cardiovascular disease in adults,” Journal of the American Geriatrics Society, vol. 59, no. 9, pp. 1596–1601, 2011.
View at: Publisher Site | Google Scholar
J. F. Navarro-Gonzalez and J. Donate-Correa, “Reduced Klotho is associated with the presence and severity of coronary artery disease,” Heart, vol. 100, no. 1, pp. 34–40, 2014.
View at: Publisher Site | Google Scholar
H. C. Pan, K. M. Chou, C. C. Lee, N. I. Yang, and C. Y. Sun, “Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients,” Atherosclerosis, vol. 276, pp. 83–90, 2018.
View at: Publisher Site | Google Scholar
M. Yamamoto, J. D. Clark, J. V. Pastor et al., “Regulation of oxidative stress by the anti-aging hormone Klotho,” The Journal of Biological Chemistry, vol. 280, no. 45, pp. 38029–38034, 2005.
View at: Publisher Site | Google Scholar
M. J. A. F. S. S. J. A. F. H. F. Ranjbaran, “Effect of vitamin D supplementation on Klotho protein, antioxidant status and nitric oxide in the elderly: a randomized, double-blinded, placebo-controlled clinical trial,” European Journal of Integrative Medicine, vol. 35, 2020.
View at: Google Scholar
R. E. Forster, P. W. Jurutka, J. C. Hsieh et al., “Vitamin D receptor controls expression of the anti-aging Klotho gene in mouse and human renal cells,” Biochemical and Biophysical Research Communications, vol. 414, no. 3, pp. 557–562, 2011.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Huiqin He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

748

Downloads

1258

Citations